Top 200 Cell and Gene Facility Index：生物製药製造商订阅资料库

本资料库资料库为世界各地的生物製药製造商提供细胞和基因疗法的开发和製造服务，积极追踪超过200个细胞/基因治疗专用设施，唯一基于订阅的资料库。

全球细胞和基因治疗市场规模，到2032年预计将达到约 822.4亿美元。

资讯图表

用于细胞和基因治疗的生物製药的世界製造集中度。
滚动浏览国家/地区名称以查看生物过程强度和容量资料：

目前细胞/基因治疗设施数：339

该资料库不断更新，包含基于过去 30年生物製药和生命科学行业评估和基准的全面资讯和分析。

"Top 200 Cell and Gene Facility Index" 对每个细胞和基因治疗 "专用" 设施进行排名，并提供生物製造区域和集群的定量区域分析。

• 生物反应器总容量
• 细胞和基因治疗服务的专业知识
• 预计未来投产的生物製药产能
• 商业和临床生物製品的数量
• 收入预测
• 优势与挑战
• 技术和专业知识等

提供的内容

• 1年订阅
• 生药设施季刊通讯（免费）
• 可以进行仪表板搜寻和排序
• 定期资料库更新
• 选项：存取即时分析师的查询输入

top200cellgene.com 的用途

• 确定理想的合作伙伴：建立细胞和基因治疗（CT/GT）合作伙伴的关键网路
• 专业知识鑑定：细胞/基因治疗、pDNA、mRNA
• 早期公司：赞助商可以确定潜在的製造合作伙伴。
• 设施位置：找到合格的员工并减少招募挑战。
• 销售区域分配：决定区域的位置以及人员配置方式。
• 市场竞争：决定竞争对手的优势和劣势。
• 不动产评估：根据当地吸引力评估设施。
• 人力资源和招募经理：寻找足够数量的经过培训且技术熟练的员工。
• 产业成长：了解产业在哪些领域成长最快。
• 新兴地区：中国、印度、拉丁美洲和中东的CT/GT 设施。
• 设施排名：CT/GT 设施在技能、就业和生产能力方面的排名。

The ONLY Global Cell and Gene facilities database subscription that actively tracks over 200+ dedicated Cell and Gene Therapy facilities providing cell therapy and gene therapy development and manufacturing services for biopharmaceuticals.

Global cell and gene therapy market size is projected to reach approximately $82.24 billion by 2032.

CONCENTRATION OF GLOBAL CELL AND GENE THERAPY BIOPHARMACEUTICAL MANUFACTURING

Current Count of Cell and Gene Facilities: 339.

Based on 30 years of evaluating and benchmarking the biopharmaceutical and life sciences industry, this database is updated continually and includes comprehensive information and insights.

"Top200Cell and Gene Facility Index" ranks each 'dedicated' cell and gene therapy facility and provides regional quantitative analysis of biomanufacturing regions and clusters.

• Total bioreactor liter capacity
• Cell and Gene Therapy service expertise
• Future Biomanufacturing capacity coming online
• Number of commercial and clinical biological products manufactured
• Revenue estimates
• Strengths and Challenges
• Technologies and expertise, and much more

WHAT YOU'LL GET:

• Full 1 year Subscription
• Biofacilities Quarterly Newsletter (Free!)
• Dashboard: Searchable and sortable
• Regular database updates
• Optional: Access to live analysts for queries and input

USES FOR THE TOP200CellGene.COM

• Identify ideal partners: develop key networks with CT/GT partners
• Identify specialized expertise: cell or gene therapy, pDNA, mRNA
• Early-stage companies: sponsors can identify potential manufacturing partners
• Facility siting: Locate qualified employees; reduce hiring challenges
• Sales territory allocations: Determine where and how to staff territories
• Market Competition: Identify competitors' strengths and weaknesses
• Real estate valuation: For facilities, based on regional attractiveness
• HR and Recruiters: Looking for a critical mass of educated and skilled staff
• Industry Growth: Find where the industry is growing most rapidly
• Emerging Regions: CT/GT Facilities in China, India, Latin America, Middle East regions
• Facility Ranking: How do CT/GT facilities rank, in skills, employment, capacity